This company listing is no longer active
Idogen Dirección
Dirección controles de criterios 1/4
Idogen's CEO is Christina Herder, appointed in Sep 2022, they has a tenure of less than a year. Their total yearly compensation is SEK454.00K , comprised of 66.1% salary and 33.9% bonuses, including company stock and options. They directly owns 0.06% of the company’s shares, worth SEK7.56K. The average tenure of the management team and the board of directors is 1.5 years and 2.7 years respectively.
Información clave
Christina Herder
Chief Executive Officer (CEO)
kr454.0k
Compensación total
| Porcentaje del salario del CEO | 66.1% |
| Permanencia del CEO | less than a year |
| Participación del CEO | 0.06% |
| Permanencia media de la dirección | 1.5yrs |
| Promedio de permanencia en la Junta Directiva | 2.7yrs |
Actualizaciones recientes de la dirección
Recent updates
Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Mar 31 2023 | n/a | n/a | -kr44m |
| Dec 31 2022 | kr454k | kr300k | -kr48m |
| Sep 30 2022 | n/a | n/a | -kr50m |
| Jun 30 2022 | n/a | n/a | -kr41m |
| Mar 31 2022 | n/a | n/a | -kr39m |
| Dec 31 2021 | kr150k | n/a | -kr39m |
| Sep 30 2021 | n/a | n/a | -kr33m |
| Jun 30 2021 | n/a | n/a | -kr33m |
| Mar 31 2021 | n/a | n/a | -kr31m |
| Dec 31 2020 | kr150k | n/a | -kr27m |
Compensación vs. Mercado: Christina's total compensation ($USD42.19K) is below average for companies of similar size in the Swedish market ($USD231.64K).
Compensación vs. Ingresos: Christina's compensation has increased whilst the company is unprofitable.
CEO
Christina Herder (62 yo)
less than a year
Permanencia
kr454,000
Compensación
Dr. Christina Herder, Ph D., served as Independent Director for Ziccum AB (publ) since April 28, 2022 until May 2023. She is Director at Beactica AB since 2021.She is a Director at Elicera Therapeutics AB...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Acting CEO & Director | less than a year | kr454.00k | 0.060% SEK 7.6k | |
| Founder & Chairman of the Scientific Advisory Board | no data | kr150.00k | 0.17% SEK 22.0k | |
| Chief Financial Officer | 7.2yrs | sin datos | 0.33% SEK 42.1k | |
| Chief Technology Officer | 9.5yrs | kr120.74k | 0.012% SEK 1.5k | |
| Chief Medical Officer | 1.5yrs | sin datos | sin datos | |
| Chief Regulatory Officer | 1.3yrs | sin datos | sin datos |
1.5yrs
Permanencia media
62yo
Promedio de edad
Equipo directivo experimentado: IDOGEN's management team is not considered experienced ( 1.5 years average tenure), which suggests a new team.
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Acting CEO & Director | 6.2yrs | kr454.00k | 0.060% SEK 7.6k | |
| Founder & Chairman of the Scientific Advisory Board | 7.8yrs | kr150.00k | 0.17% SEK 22.0k | |
| Independent Chairman of the Board | 7.3yrs | kr407.00k | 0.15% SEK 18.9k | |
| Member of Scientific Advisory Board | 7.8yrs | sin datos | sin datos | |
| Member of Scientific Advisory Board | 2.3yrs | sin datos | sin datos | |
| Independent Director | 3.2yrs | kr150.00k | 0.089% SEK 11.1k | |
| Member of Scientific Advisory Board | 2.3yrs | sin datos | sin datos | |
| Member of Scientific Advisory Board | 2.3yrs | sin datos | sin datos | |
| Member of Scientific Advisory Board | less than a year | sin datos | sin datos | |
| Member of Scientific Advisory Board | less than a year | sin datos | sin datos |
2.7yrs
Permanencia media
64.5yo
Promedio de edad
Junta con experiencia: IDOGEN's board of directors are not considered experienced ( 2.7 years average tenure), which suggests a new board.